Paying users zone. Data is covered by hidden.

  • Get to Amgen Inc. for $17.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Profitability Analysis

Difficulty: Beginner


Ratios (Summary)

Amgen Inc., profitability ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Return on Sales
Gross profit margin hidden hidden hidden hidden hidden
Operating profit margin hidden hidden hidden hidden hidden
Net profit margin hidden hidden hidden hidden hidden
Return on Investment
Return on equity (ROE) hidden hidden hidden hidden hidden
Return on assets (ROA) hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-24).

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Amgen Inc.'s gross profit margin improved from 2015 to 2016 and from 2016 to 2017.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Amgen Inc.'s operating profit margin improved from 2015 to 2016 and from 2016 to 2017.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Amgen Inc.'s net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders' equity. Amgen Inc.'s ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.
ROA A profitability ratio calculated as net income divided by total assets. Amgen Inc.'s ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Gross Profit Margin

Amgen Inc., gross profit margin calculation

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Gross profit from product sales hidden hidden hidden hidden hidden
Product sales hidden hidden hidden hidden hidden
Ratio
Gross profit margin1 hidden hidden hidden hidden hidden
Benchmarks
Gross Profit Margin, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-24).

2017 Calculations

1 Gross profit margin = 100 × Gross profit from product sales ÷ Product sales
= 100 × hidden ÷ hidden = hidden

Ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Amgen Inc.'s gross profit margin improved from 2015 to 2016 and from 2016 to 2017.

Operating Profit Margin

Amgen Inc., operating profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Operating income hidden hidden hidden hidden hidden
Product sales hidden hidden hidden hidden hidden
Ratio
Operating profit margin1 hidden hidden hidden hidden hidden
Benchmarks
Operating Profit Margin, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Operating Profit Margin, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Operating Profit Margin, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-24).

2017 Calculations

1 Operating profit margin = 100 × Operating income ÷ Product sales
= 100 × hidden ÷ hidden = hidden

Ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Amgen Inc.'s operating profit margin improved from 2015 to 2016 and from 2016 to 2017.

Net Profit Margin

Amgen Inc., net profit margin calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net income hidden hidden hidden hidden hidden
Product sales hidden hidden hidden hidden hidden
Ratio
Net profit margin1 hidden hidden hidden hidden hidden
Benchmarks
Net Profit Margin, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Net Profit Margin, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Net Profit Margin, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-24).

2017 Calculations

1 Net profit margin = 100 × Net income ÷ Product sales
= 100 × hidden ÷ hidden = hidden

Ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Amgen Inc.'s net profit margin improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Return on Equity (ROE)

Amgen Inc., ROE calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net income hidden hidden hidden hidden hidden
Stockholders' equity hidden hidden hidden hidden hidden
Ratio
ROE1 hidden hidden hidden hidden hidden
Benchmarks
ROE, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
ROE, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
ROE, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-24).

2017 Calculations

1 ROE = 100 × Net income ÷ Stockholders' equity
= 100 × hidden ÷ hidden = hidden

Ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders' equity. Amgen Inc.'s ROE improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.

Return on Assets (ROA)

Amgen Inc., ROA calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Selected Financial Data (USD $ in millions)
Net income hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Ratio
ROA1 hidden hidden hidden hidden hidden
Benchmarks
ROA, Competitors
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
ROA, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
ROA, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-14), 10-K (filing date: 2016-02-16), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-24).

2017 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × hidden ÷ hidden = hidden

Ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Amgen Inc.'s ROA improved from 2015 to 2016 but then deteriorated significantly from 2016 to 2017.